ROIV Stock Analysis: Buy, Sell, or Hold?
ROIV - Roivant Sciences Ltd. Common Shares
$40.82
-0.12 (-0.29%)
▼
5d:
+18.63%
30d:
+12.89%
90d:
+37.3%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Sep 8, 2026 at $41.84 · last confirmed Sep 8, 2026
Strength: 7.9/10
Get Alerted When ROIV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ROIV shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ROIV shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ROIV is currently trading at $40.82, which is considered extended relative to its 30-day fair value range of $34.26 to $38.68.
Technical Outlook: Technically, ROIV is in a strong uptrend. Immediate support is located at $33.43, while resistance sits at $42.50.
Market Sentiment: ROIV scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $45.59 (+11.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ROIV is in a strong uptrend. Immediate support is located at $33.43, while resistance sits at $42.50.
Market Sentiment: ROIV scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $45.59 (+11.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$34.26 -
$38.68
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
18.4%
Protect Your Profits
Holding ROIV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.5% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($45.59)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$34.26 -
$38.68
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$33.43
Resistance Level
$42.50
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-35.33
Wall Street Target
$45.59
(+11.4%)
Revenue Growth (YoY)
-33.5%
Earnings Growth (YoY)
-96.1%
Share & Embed Analysis
Last updated: September 11, 2026 4:14 PM ET
Data refreshes hourly during market hours. Next update: 5:14 PM
Data refreshes hourly during market hours. Next update: 5:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ROIV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric Venker
SELL
200000 shares
2026-04-20
Matthew Gline
SELL
289774 shares
2026-04-16
Jennifer Humes
SELL
13538 shares
2026-04-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 50 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 44 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 43 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$289 | 59 HOLD |
Advanced ROIV Option Strategies
Professional options setups generated by AI based on today's ROIV price and gamma walls.
